Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic.
作者信息
Abu-Raya Bahaa, Gantt Soren, Sadarangani Manish
机构信息
Vaccine Evaluation Center, BC Children's Hospital Research Institute, and Division of Infectious Diseases, Department of Pediatrics, University of British Columbia, Vancouver, BC
Vaccine Evaluation Center, BC Children's Hospital Research Institute, and Division of Infectious Diseases, Department of Pediatrics, University of British Columbia, Vancouver, BC.
出版信息
CMAJ. 2020 Aug 24;192(34):E982-E985. doi: 10.1503/cmaj.201237. Epub 2020 Jul 9.
Abstract
摘要
相似文献
1
Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic.新冠疫情期间评估新冠病毒疫苗的挑战。
CMAJ. 2020 Aug 24;192(34):E982-E985. doi: 10.1503/cmaj.201237. Epub 2020 Jul 9.
2
[COVID-19: Impact of a pandemic].[新冠疫情：一场大流行病的影响]
Rev Argent Microbiol. 2020 Jul-Sep;52(3):167-168. doi: 10.1016/j.ram.2020.09.003.
3
Developing Covid-19 Vaccines at Pandemic Speed.以大流行速度研发新冠疫苗。
N Engl J Med. 2020 May 21;382(21):1969-1973. doi: 10.1056/NEJMp2005630. Epub 2020 Mar 30.
4
Progress and Concept for COVID-19 Vaccine Development.新型冠状病毒肺炎疫苗研发进展与理念
Biotechnol J. 2020 Jun;15(6):e2000147. doi: 10.1002/biot.202000147. Epub 2020 May 7.
5
COVID-19 pandemic in India.印度的新冠疫情。
Eur Heart J. 2020 Oct 21;41(40):3874-3876. doi: 10.1093/eurheartj/ehaa493.
6
The catch-22 of the COVID-19 "lockdown".新冠疫情“封锁”的第二十二条军规。
Adv Respir Med. 2020;88(3):285-286. doi: 10.5603/ARM.a2020.0097.
7
Management of COVID-19 Crisis in Guilan Province in Northern Iran.伊朗北部吉兰省新冠疫情危机的管理
Arch Iran Med. 2020 Jul 1;23(7):511-513. doi: 10.34172/aim.2020.52.
8
Addressing COVID-19 in Afghanistan: What are the efforts and challenges?应对阿富汗的新冠疫情：有哪些努力和挑战？
J Glob Health. 2020 Dec;10(2):020341. doi: 10.7189/jogh.10.020341.
9
Indian response to COVID-19: Expertise and transparency.印度对新冠疫情的应对：专业知识与透明度。
Indian J Public Health. 2020 Jun;64(Supplement):S243-S244. doi: 10.4103/ijph.IJPH_504_20.
10
COVID-19: leaving no one behind in Latin America.新冠疫情：不让拉丁美洲任何人掉队。
Lancet. 2020 Oct 10;396(10257):1070. doi: 10.1016/S0140-6736(20)32073-0.
引用本文的文献
1
SARS-CoV-2 vaccination in solid-organ transplant recipients: What the clinician needs to know.SARS-CoV-2 疫苗接种在实体器官移植受者中的应用：临床医生需要了解的知识。
Transpl Int. 2021 Oct;34(10):1776-1788. doi: 10.1111/tri.14029. Epub 2021 Sep 20.
2
Optimizing COVID-19 vaccine distribution across the United States using deterministic and stochastic recurrent neural networks.利用确定性和随机递归神经网络优化美国的 COVID-19 疫苗分发。
PLoS One. 2021 Jul 6;16(7):e0253925. doi: 10.1371/journal.pone.0253925. eCollection 2021.
3
Prediction and follow-up of risk factors for severe SARS-CoV-2 pneumonia and application of CT visual scoring.预测和随访严重 SARS-CoV-2 肺炎的危险因素及 CT 视觉评分的应用。
Technol Health Care. 2021;29(S1):153-164. doi: 10.3233/THC-218016.
本文引用的文献
1
Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020.2020 年 4 月 10 日至 11 日，加利福尼亚州洛杉矶县成年人中 SARS-CoV-2 特异性抗体的血清流行率。
JAMA. 2020 Jun 16;323(23):2425-2427. doi: 10.1001/jama.2020.8279.
2
COVID-19 vaccine design: the Janus face of immune enhancement.COVID-19 疫苗设计：免疫增强的两面性。
Nat Rev Immunol. 2020 Jun;20(6):347-348. doi: 10.1038/s41577-020-0323-4. Epub 2020 Apr 28.
3
Generating randomized trial evidence to optimize treatment in the COVID-19 pandemic.生成随机试验证据以优化新冠疫情中的治疗。
CMAJ. 2020 Apr 14;192(15):E405-E407. doi: 10.1503/cmaj.200438. Epub 2020 Mar 26.
4
COVID-19 and African Americans.新冠病毒与非裔美国人。
JAMA. 2020 May 19;323(19):1891-1892. doi: 10.1001/jama.2020.6548.
5
Projecting demand for critical care beds during COVID-19 outbreaks in Canada.预测加拿大 COVID-19 疫情期间重症监护病床的需求。
CMAJ. 2020 May 11;192(19):E489-E496. doi: 10.1503/cmaj.200457. Epub 2020 Apr 8.
6
Mathematical modelling of COVID-19 transmission and mitigation strategies in the population of Ontario, Canada.加拿大安大略省 COVID-19 传播及其在人群中缓解策略的数学建模。
CMAJ. 2020 May 11;192(19):E497-E505. doi: 10.1503/cmaj.200476. Epub 2020 Apr 8.
7
SARS-CoV-2 Vaccines: Status Report.SARS-CoV-2 疫苗：现状报告。
Immunity. 2020 Apr 14;52(4):583-589. doi: 10.1016/j.immuni.2020.03.007. Epub 2020 Apr 6.
8
Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.意大利新冠肺炎死亡患者的病死率及特征
JAMA. 2020 May 12;323(18):1775-1776. doi: 10.1001/jama.2020.4683.
9
Critique of World Health Organization Recommendation of a Dengue Vaccine.对世界卫生组织登革热疫苗推荐意见的批评
J Infect Dis. 2016 Dec 15;214(12):1793-1795. doi: 10.1093/infdis/jiw340. Epub 2016 Aug 5.
10
Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus.接种 SARS 冠状病毒疫苗会导致在 SARS 病毒攻击时肺部免疫病理学发生。
PLoS One. 2012;7(4):e35421. doi: 10.1371/journal.pone.0035421. Epub 2012 Apr 20.
Zotero 插件